Diagnostics And Consultation Center Convex Ltd.

Az itteni vizsgálatok

Miről szól a helyszín 76 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Asztma13 vizsgálat
• Colitis ulcerosa11 vizsgálat
• Sclerosis multiplex (SM)10 vizsgálat
• Krónikus obstruktív tüdőbetegség (COPD)5 vizsgálat
• Idiopátiás tüdőfibrózis4 vizsgálat
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)4 vizsgálat
• Szívelégtelenség4 vizsgálat
• Crohn-betegség3 vizsgálat
• Lupus (SLE)3 vizsgálat
• Stroke (szélütés)3 vizsgálat
• Chronic spontaneous urticaria2 vizsgálat
• Elhízás2 vizsgálat
• és még 13

Fázis

• 3. fázis37 vizsgálat
• 2. fázis33 vizsgálat
• 1. fázis3 vizsgálat
• 1/2. fázis1 vizsgálat
• 2/3. fázis1 vizsgálat
• 4. fázis1 vizsgálat

Állapot

• Lezárult28 vizsgálat
• Fut, nem toboroz20 vizsgálat
• Toboroz18 vizsgálat
• Még nem toboroz10 vizsgálat

Fő szponzor

• Chiesi Farmaceutici S.p.A.5 vizsgálat
• Janssen Research & Development, LLC5 vizsgálat
• Amgen Inc.4 vizsgálat
• AstraZeneca4 vizsgálat
• Sanofi-Aventis Recherche & Developpement4 vizsgálat
• és még 43

Futó vizsgálatok

• Még nem toboroz

  A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved Ocrevus

  NCT07606521· 1. fázis· Polpharma Biologics International AG· Forrás

• Toboroz

  A Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

  2025-525016-41-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

  NCT07725939· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

  NCT07532265· 2. fázis· Kinaset Therapeutics Inc· Forrás

• Toboroz

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])

  NCT07666490· 4. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Toboroz

  Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes

  NCT07216235· 3. fázis· Zydus Therapeutics Inc.· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)

  2025-524005-32-00· 2. fázis· Elevara Medicines Limited· Forrás

• Toboroz

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· 2. fázis· Rein Therapeutics· Forrás

• Toboroz

  Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

  NCT07230288· 2. fázis· AbbVie· Forrás

• Toboroz

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  NCT07325292· 3. fázis· Sanofi· Forrás

• Toboroz

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  NCT07276724· 3. fázis· Generate Biomedicines· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· 3. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  Trial of Sibeprenlimab in the Treatment of Sjögren’s Disease

  2024-516295-14-00· 2. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás

• Toboroz

  Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

  NCT07120503· 2. fázis· Windward Bio· Forrás

• Toboroz

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  NCT06961214· 3. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

  NCT06847724· 3. fázis· Sandoz· Forrás

• Fut, nem toboroz

  A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

  NCT06966479· 2. fázis· Upstream Bio Inc.· Forrás

• Toboroz

  Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

  NCT06929806· 3. fázis· Pharmacosmos A/S· Forrás

• Toboroz

  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT07032662· 2. fázis· Immunovant Sciences GmbH· Forrás

• Fut, nem toboroz

  A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

  NCT06748053· 2. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

  NCT06754462· 2. fázis· Immunovant Sciences GmbH· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  2023-504022-19-01· 3. fázis· AstraZeneca AB· Forrás

• Fut, nem toboroz

  A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  NCT06655155· 2. fázis· argenx· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Obexelimab in Patients with Systemic Lupus Erythematosus

  2024-510584-37-00· 2. fázis· Zenas Biopharma (USA) LLC· Forrás

• Toboroz

  Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis

  2023-504358-36-00· 3. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Fut, nem toboroz

  Phase IIa Study Evaluating AZD7798 in Crohn's Disease

  NCT06450197· 2. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)

  NCT06455202· 3. fázis· Celldex Therapeutics· Forrás

• Fut, nem toboroz

  Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

  NCT06141486· 3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

  NCT06052267· 3. fázis· Teva Branded Pharmaceutical Products R&D LLC· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

  NCT05639114· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05528510· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

  NCT04752774· 1/2. fázis· Ipsen· Forrás

• Fut, nem toboroz

  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

  NCT04280718· 2. fázis· argenx· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· 2/3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

  NCT03950232· 3. fázis· Pfizer· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Asztma4 toboroz
• Idiopátiás tüdőfibrózis4 toboroz
• Sclerosis multiplex (SM)4 toboroz
• Szívelégtelenség3 toboroz
• Elhízás2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Tüdőrák2 toboroz
• Chronic spontaneous urticaria1 toboroz
• Colitis ulcerosa1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Peripheral artery disease1 toboroz
• Pitvarfibrilláció1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Rheumatoid arthritis1 toboroz
• Stroke (szélütés)1 toboroz

Lezárt vizsgálatok

• Lezárult

  A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis

  NCT07222189· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Toboroz

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  NCT06920004· 3. fázis· argenx· Forrás

• Lezárult

  Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP

  2024-515386-34-00· 2. fázis· Nuvig Therapeutics Inc.· Forrás

• Lezárult

  A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.

  NCT06637631· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Még nem toboroz

  A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD

  NCT06731959· 2. fázis· Aer Therapeutics· Forrás

• Lezárult

  A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome

  NCT06312020· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB310 in Patients with Active, Mild to Moderate Ulcerative Colitis (COMPOSER-1)

  2023-507376-50-00· 1. fázis· Microbiotica Limited· Forrás

• Lezárult

  A Phase 2, Double-blind, Placebo-controlled, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

  NCT06376045· 2. fázis· Amgen Inc.· Forrás

• Lezárult

  A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

  NCT06920771· 3. fázis· HAL Allergy· Forrás

• Lezárult

  Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis

  2023-508679-34-00· 2. fázis· Anaptysbio Inc.· Forrás

• Lezárult

  A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative colitis

  2023-507340-36-00· 1. fázis· Enthera S.r.l.· Forrás

• Lezárult

  A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

  NCT06323928· 2. fázis· H. Lundbeck A/S· Forrás

• Lezárult

  A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

  NCT06168409· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· 2. fázis· Upstream Bio Inc.· Forrás

• Lezárult

  Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

  NCT06017609· 2. fázis· Shionogi Inc.· Forrás

• Lezárult

  Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

  NCT06264674· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Lezárult

  A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled on inhaled corticosteroid and long-acting beta 2 agonist therapy

  2022-502854-16-00· 2. fázis· Rapt Therapeutics Inc.· Forrás

• Lezárult

  Efficacy and safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund maintenance therapy

  2022-502208-64-00· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

  NCT06034743· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

  NCT05798520· 2. fázis· Biogen· Forrás

• Lezárult

  Long-term Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis

  NCT05672199· 2. fázis· Amgen Inc.· Forrás

• Lezárult

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· 3. fázis· Abivax S.A.· Forrás

• Lezárult

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Phase 2 double-blind, randomized, placebo-controlled study evaluating the effect of SAR443820 on serum neurofilament levels in participants with multiple sclerosis, followed by an open-label long-term extension period

  2023-509078-45-00· 2. fázis· Sanofi-Aventis Recherche & Developpement· Forrás

• Lezárult

  A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

  NCT04320342· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Lezárult

  Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Colitis

  NCT04987307· 2. fázis· Amgen Inc.· Forrás

• Fut, nem toboroz

  Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

  NCT05138133· 3. fázis· AstraZeneca· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás